Skip to content

Drug interactions

Aprepitant + Crofelemer

Severity: Minor

Aprepitant and Crofelemer: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Crofelemer is minimally absorbed, so its effects on CYP3A4 are limited to the gut and are unlikely to alter aprepitant exposure meaningfully. Clinical impact is probably small.

What this interaction means in plain words

Aprepitant and Crofelemer have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Aprepitant belongs to Gastrointestinal Tract; Crofelemer belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Crofelemer may inhibit intestinal CYP3A4 locally, possibly slightly raising aprepitant absorption.

What to do

No dose adjustment is needed. Be aware of increased aprepitant adverse effects if they occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Crofelemer, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Crofelemer?

MediHelp rates the interaction as minor. Aprepitant and Crofelemer have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Crofelemer is minimally absorbed, so its effects on CYP3A4 are limited to the gut and are unlikely to alter aprepitant exposure meaningfully. Clinical impact is probably small.

How serious is the interaction between Aprepitant and Crofelemer?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed. Be aware of increased aprepitant adverse effects if they occur.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in